Skip to main content
Veterinary Medicines

TAbic IB VAR206, effervescent tablets for suspension for chickens

Authorised
  • Avian infectious bronchitis virus, strain 2-06, Live

Product identification

Medicine name:
TAbic IB VAR206, effervescent tablets for suspension for chickens
TAbic IB VAR206 putojošās tabletes suspensijas pagatavošanai vistām
Active substance:
  • Avian infectious bronchitis virus, strain 2-06, Live
Target species:
  • Chicken (hen)
Route of administration:
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, strain 2-06, Live
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Available only in Latvian
  • Tablets (1500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (3000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (3500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (4000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (4500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (1500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (3000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (3500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (4000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (4500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Synoptis Industrial Sp. z o.o.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/19/0082
Date of authorisation status change:
Reference member state:
  • Poland
Procedure number:
  • PL/V/0109/001
Concerned member states:
  • Bulgaria
  • Czechia
  • Latvia
  • Lithuania
  • Romania
  • Slovakia
  • Slovenia

Documents

Combined File of all Documents

English (PDF)
Published on: 7/02/2024
Updated on: 8/02/2024
Download
Latvian (PDF)
Published on: 5/03/2025